摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,5-dioxopyrrolidin-1-yl 5-(5,11-bis((1,3-dihydroxypropan-2-yloxy)methyl)-1,15-dihydroxy-2,14-bis(hydroxymethyl)-3,6,10,13-tetraoxapentadecan-8-ylamino)-5-oxopentanoate | 1382190-37-5

中文名称
——
中文别名
——
英文名称
2,5-dioxopyrrolidin-1-yl 5-(5,11-bis((1,3-dihydroxypropan-2-yloxy)methyl)-1,15-dihydroxy-2,14-bis(hydroxymethyl)-3,6,10,13-tetraoxapentadecan-8-ylamino)-5-oxopentanoate
英文别名
——
2,5-dioxopyrrolidin-1-yl 5-(5,11-bis((1,3-dihydroxypropan-2-yloxy)methyl)-1,15-dihydroxy-2,14-bis(hydroxymethyl)-3,6,10,13-tetraoxapentadecan-8-ylamino)-5-oxopentanoate化学式
CAS
1382190-37-5
化学式
C30H54N2O19
mdl
——
分子量
746.761
InChiKey
UHMLXENJBIONAN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -5.5
  • 重原子数:
    51.0
  • 可旋转键数:
    32.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.87
  • 拓扑面积:
    310.0
  • 氢给体数:
    9.0
  • 氢受体数:
    19.0

反应信息

  • 作为反应物:
    描述:
    2,5-dioxopyrrolidin-1-yl 5-(5,11-bis((1,3-dihydroxypropan-2-yloxy)methyl)-1,15-dihydroxy-2,14-bis(hydroxymethyl)-3,6,10,13-tetraoxapentadecan-8-ylamino)-5-oxopentanoate3'-N-debenzoylpaclitaxelN,N-二甲基甲酰胺 为溶剂, 反应 40.0h, 以80%的产率得到(1S,2S,4S,9S,10S,15S,3R,7R,12R)-4,12-diacetyloxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-2-phenylcarbonyloxy-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-15-yl (3S,2R)-2-hydroxy-3-[4-(N-{2-(2-[2-hydroxy-1-(hydroxymethyl)ethoxy]-1-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}ethoxy)-1-[(2-[2-hydroxy-1-(hydroxymethyl)ethoxy]-1-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}ethoxy)methyl]ethyl}carbamoyl)butanoylamino]-3-phenylpropanoate
    参考文献:
    名称:
    Synthesis of Paclitaxel–BGL Conjugates
    摘要:
    Four kinds of symmetrically branched oligoglyceryl trimeric (BGL003)-paclitaxel conjugates and a corresponding heptameric (BGL007) conjugate were synthesized. Molecular weights of all the compounds were less than two times that of paclitaxel. The anti-tumor activity of the most water-soluble BGL003 conjugate was examined and found to be preserved in spite of the chemical modification that is displacement of the N3'-debenzoyl residue with the BGL003 succinyl residue. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.07.031
  • 作为产物:
    描述:
    氢气 、 palladium(II) hydroxide 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以17 mg的产率得到2,5-dioxopyrrolidin-1-yl 5-(5,11-bis((1,3-dihydroxypropan-2-yloxy)methyl)-1,15-dihydroxy-2,14-bis(hydroxymethyl)-3,6,10,13-tetraoxapentadecan-8-ylamino)-5-oxopentanoate
    参考文献:
    名称:
    Synthesis of Paclitaxel–BGL Conjugates
    摘要:
    Four kinds of symmetrically branched oligoglyceryl trimeric (BGL003)-paclitaxel conjugates and a corresponding heptameric (BGL007) conjugate were synthesized. Molecular weights of all the compounds were less than two times that of paclitaxel. The anti-tumor activity of the most water-soluble BGL003 conjugate was examined and found to be preserved in spite of the chemical modification that is displacement of the N3'-debenzoyl residue with the BGL003 succinyl residue. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.07.031
点击查看最新优质反应信息